Patents by Inventor Jorge Valdes

Jorge Valdes has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11399742
    Abstract: Systems and methods for a continuous monitoring of analyte values received from an analyte sensor system are provided. One method for a wireless data communication between an analyte sensor system and a mobile device involves storing identification information associated with a transceiver of the analyte sensor system, the identification information entered by a user of the mobile device via a custom application running on the mobile device; causing the custom application to enter a background mode; searching for advertisement signals; receiving an advertisement signal from the transceiver; authenticating the transceiver based on the identification information; prompting the user to bring the custom application to a foreground mode; causing the custom application to request a confirmation from the user that a data connection with the transceiver is desired; receiving the confirmation from the user; and completing the data connection with the transceiver.
    Type: Grant
    Filed: September 28, 2020
    Date of Patent: August 2, 2022
    Assignee: Dexcom, Inc.
    Inventors: Jose Hector Hernandez-Rosas, Shawn Larvenz, Mark Dervaes, Indrawati Gauba, Michael Robert Mensinger, Eric Cohen, Brian Christopher Smith, Jorge Valdes, Jacob S. Leach
  • Patent number: 11295855
    Abstract: Disclosed are systems and methods for providing automated or semi-automated technical support for patients using medical devices, such as continuous glucose monitoring systems. Disclosed embodiments of automated tech support system include collection and storage of copies of streams of medical device data on multiple servers, analysis and comparison of data streams, remote tech support initiation and usage of the automated tech support system for providing improved products and services by storing and analyzing historical tech support data.
    Type: Grant
    Filed: November 7, 2017
    Date of Patent: April 5, 2022
    Assignee: Dexcom, Inc.
    Inventors: Andrew Attila Pal, Leif N. Bowman, Eric Cohen, Basab Dattaray, Edward Day, Apurv Ullas Kamath, Aarthi Mahalingam, Dana Minor, Scott A. Moss, Neil Puri, Eli Reihman, Conrad Woods, Laurie L. Berg, Jorge Valdes
  • Publication number: 20220071487
    Abstract: Systems, devices, and methods are disclosed for wireless communication of analyte data. One such method includes, during a first interval, establishing a first connection between an analyte sensor system and a display device. During the first connection, the method includes exchanging information related to authentication between the analyte sensor system and the display device. The method includes making a determination regarding whether authentication was performed during the first interval. During a second interval, the method may include establishing a second connection between the analyte sensor system and the display device for transmission of an encrypted analyte value, and bypassing the exchanging of information related to authentication performed during the first connection.
    Type: Application
    Filed: November 16, 2021
    Publication date: March 10, 2022
    Inventors: Aditya Mandapaka, Jorge Valdes, Jeffrey R. Wedekind, Eric Cohen, Douglas William Burnette, Francis William Pascual, Hari Hampapuram, Mark Dervaes, Michael Robert Mensinger
  • Publication number: 20210361162
    Abstract: Various embodiments relate generally to continuous monitoring of analyte values received from an analyte sensor system. In some example embodiments, there is provided a method that includes receiving sensor information, calculating and storing estimated analyte measurement values based upon the received sensor information. The method also includes determining one or more communication conditions, and instructing a transceiver to advertise to a first display device in accordance with one or more communication variables based upon the one or more communication conditions. The method then transmits the estimated analyte measurement values to the at least first display device. Related systems, methods, and articles of manufacture are also described.
    Type: Application
    Filed: August 2, 2021
    Publication date: November 25, 2021
    Inventors: Douglas William Burnette, Eric Cohen, Jason Halac, Hari Hampapuram, Lauren Hruby Jepson, Shawn Larvenz, Aditya Mandapaka, Michael Robert Mensinger, Jorge Valdes, Jeffrey R. Wedekind
  • Patent number: 11109756
    Abstract: Various embodiments relate generally to continuous monitoring of analyte values received from an analyte sensor system. In some example embodiments, there is provided a method that includes receiving sensor information, calculating and storing estimated analyte measurement values based upon the received sensor information. The method also includes determining one or more communication conditions, and instructing a transceiver to advertise to a first display device in accordance with one or more communication variables based upon the one or more communication conditions. The method then transmits the estimated analyte measurement values to the at least first display device. Related systems, methods, and articles of manufacture are also described.
    Type: Grant
    Filed: December 20, 2016
    Date of Patent: September 7, 2021
    Assignee: DexCom, Inc.
    Inventors: Douglas William Burnette, Eric Cohen, Jason Halac, Hari Hampapuram, Lauren Hruby Jepson, Shawn Larvenz, Aditya Mandapaka, Michael Robert Mensinger, Jorge Valdes, Jeffrey R. Wedekind
  • Publication number: 20210260289
    Abstract: Machine learning in an artificial pancreas is described. An artificial pancreas system may include a wearable glucose monitoring device, an insulin delivery system, and a computing device. Broadly speaking, the wearable glucose monitoring device provides glucose measurements of a person continuously. The artificial pancreas algorithm, which may be implemented at the computing device, determines doses of insulin to deliver to the person based on a variety of aspects for the purpose of maintaining the person's glucose within a target range, as indicated by those glucose measurements. The insulin delivery system then delivers those determined doses to the person. As the artificial pancreas algorithm determines insulin doses for the person over time and effectiveness of the insulin doses to maintain the person's glucose level in the target range is observed, an underlying model of the artificial pancreas algorithm may be updated to better determine insulin doses.
    Type: Application
    Filed: December 7, 2020
    Publication date: August 26, 2021
    Inventors: Apurv Ullas Kamath, Derek James Escobar, Sumitaka Mikami, Hari Hampapuram, Benjamin Elrod West, Nathanael Paul, Naresh C. Bhavaraju, Michael Robert Mensinger, Gary A. Morris, Andrew Attila Pal, Eli Reihman, Scott M. Belliveau, Katherine Yerre Koehler, Nicholas Polytaridis, Rian Draeger, Jorge Valdes, David Price, Peter C. Simpson, Edward Sweeney
  • Publication number: 20210260286
    Abstract: Machine learning in an artificial pancreas is described. An artificial pancreas system may include a wearable glucose monitoring device, an insulin delivery system, and a computing device. Broadly speaking, the wearable glucose monitoring device provides glucose measurements of a person continuously. The artificial pancreas algorithm, which may be implemented at the computing device, determines doses of insulin to deliver to the person based on a variety of aspects for the purpose of maintaining the person's glucose within a target range, as indicated by those glucose measurements. The insulin delivery system then delivers those determined doses to the person. As the artificial pancreas algorithm determines insulin doses for the person over time and effectiveness of the insulin doses to maintain the person's glucose level in the target range is observed, an underlying model of the artificial pancreas algorithm may be updated to better determine insulin doses.
    Type: Application
    Filed: December 7, 2020
    Publication date: August 26, 2021
    Inventors: Apurv Ullas Kamath, Derek James Escobar, Sumitaka Mikami, Hari Hampapuram, Benjamin Elrod West, Nathanael Paul, Naresh C. Bhavaraju, Michael Robert Mensinger, Gary A. Morris, Andrew Attila Pal, Eli Reihman, Scott M. Belliveau, Katherine Yerre Koehler, Nicholas Polytaridis, Rian Draeger, Jorge Valdes, David Price, Peter C. Simpson, Edward Sweeney
  • Publication number: 20210260287
    Abstract: Machine learning in an artificial pancreas is described. An artificial pancreas system may include a wearable glucose monitoring device, an insulin delivery system, and a computing device. Broadly speaking, the wearable glucose monitoring device provides glucose measurements of a person continuously. The artificial pancreas algorithm, which may be implemented at the computing device, determines doses of insulin to deliver to the person based on a variety of aspects for the purpose of maintaining the person's glucose within a target range, as indicated by those glucose measurements. The insulin delivery system then delivers those determined doses to the person. As the artificial pancreas algorithm determines insulin doses for the person over time and effectiveness of the insulin doses to maintain the person's glucose level in the target range is observed, an underlying model of the artificial pancreas algorithm may be updated to better determine insulin doses.
    Type: Application
    Filed: December 7, 2020
    Publication date: August 26, 2021
    Inventors: Apurv Ullas Kamath, Derek James Escobar, Sumitaka Mikami, Hari Hampapuram, Benjamin Elrod West, Nathanael Paul, Naresh C. Bhavaraju, Michael Robert Mensinger, Gary A. Morris, Andrew Attila Pal, Eli Reihman, Scott M. Belliveau, Katherine Yerre Koehler, Nicholas Polytaridis, Rian Draeger, Jorge Valdes, David Price, Peter C. Simpson, Edward Sweeney
  • Publication number: 20210259591
    Abstract: Machine learning in an artificial pancreas is described. An artificial pancreas system may include a wearable glucose monitoring device, an insulin delivery system, and a computing device. Broadly speaking, the wearable glucose monitoring device provides glucose measurements of a person continuously. The artificial pancreas algorithm, which may be implemented at the computing device, determines doses of insulin to deliver to the person based on a variety of aspects for the purpose of maintaining the person's glucose within a target range, as indicated by those glucose measurements. The insulin delivery system then delivers those determined doses to the person. As the artificial pancreas algorithm determines insulin doses for the person over time and effectiveness of the insulin doses to maintain the person's glucose level in the target range is observed, an underlying model of the artificial pancreas algorithm may be updated to better determine insulin doses.
    Type: Application
    Filed: December 7, 2020
    Publication date: August 26, 2021
    Inventors: Apurv Ullas Kamath, Derek James Escobar, Sumitaka Mikami, Hari Hampapuram, Benjamin Elrod West, Nathanael Paul, Naresh C. Bhavaraju, Michael Robert Mensinger, Gary A. Morris, Andrew Attila Pal, Eli Reihman, Scott M. Belliveau, Katherine Yerre Koehler, Nicholas Polytaridis, Rian Draeger, Jorge Valdes, David Price, Peter C. Simpson, Edward Sweeney
  • Publication number: 20210260288
    Abstract: Machine learning in an artificial pancreas is described. An artificial pancreas system may include a wearable glucose monitoring device, an insulin delivery system, and a computing device. Broadly speaking, the wearable glucose monitoring device provides glucose measurements of a person continuously. The artificial pancreas algorithm, which may be implemented at the computing device, determines doses of insulin to deliver to the person based on a variety of aspects for the purpose of maintaining the person's glucose within a target range, as indicated by those glucose measurements. The insulin delivery system then delivers those determined doses to the person. As the artificial pancreas algorithm determines insulin doses for the person over time and effectiveness of the insulin doses to maintain the person's glucose level in the target range is observed, an underlying model of the artificial pancreas algorithm may be updated to better determine insulin doses.
    Type: Application
    Filed: December 7, 2020
    Publication date: August 26, 2021
    Inventors: Apurv Ullas Kamath, Derek James Escobar, Sumitaka Mikami, Hari Hampapuram, Benjamin Elrod West, Nathanael Paul, Naresh C. Bhavaraju, Michael Robert Mensinger, Gary A. Morris, Andrew Attila Pal, Eli Reihman, Scott M. Belliveau, Katherine Yerre Koehler, Nicholas Polytaridis, Rian Draeger, Jorge Valdes, David Price, Peter C. Simpson, Edward Sweeney
  • Publication number: 20210251484
    Abstract: The present disclosure relates to systems, devices and methods for receiving biosensor data acquired by a medical device, e.g., relating to glucose concentration values, and controlling the access and distribution of that data. In some embodiments, systems and methods are disclosed for monitoring glucose levels, displaying data relating to glucose values and metabolic health information, and controlling distribution of glucose data between applications executing on a computer, such as a smart phone. In some embodiments, systems and methods are disclosed for controlling access to medical data such as continuously monitored glucose levels, synchronizing health data relating to glucose levels between multiple applications executing on a computer, and/or encrypting data.
    Type: Application
    Filed: March 12, 2021
    Publication date: August 19, 2021
    Inventors: Michael Robert Mensinger, Esteban Cabrera, Jr., Eric Cohen, Nathaniel David Heintzman, Apurv Ullas Kamath, Gary A. Morris, Andrew Attila Pal, Eli Reihman, Jorge Valdes
  • Patent number: 11006829
    Abstract: Systems, devices, and methods are disclosed for wireless communication of analyte data. One such method includes, during a first interval, establishing a first connection between an analyte sensor system and a display device. During the first connection, the method includes exchanging information related to authentication between the analyte sensor system and the display device. The method includes making a determination regarding whether authentication was performed during the first interval. During a second interval, the method may include establishing a second connection between the analyte sensor system and the display device for transmission of an encrypted analyte value, and bypassing the exchanging of information related to authentication performed during the first connection.
    Type: Grant
    Filed: January 15, 2021
    Date of Patent: May 18, 2021
    Assignee: DexCom, Inc.
    Inventors: Aditya Mandapaka, Jorge Valdes, Jeffrey R. Wedekind, Eric Cohen, Douglas William Burnette, Francis William Pascual, Hari Hampapuram, Mark Dervaes, Michael Robert Mensinger
  • Publication number: 20210137380
    Abstract: Systems, devices, and methods are disclosed for wireless communication of analyte data. One such method includes, during a first interval, establishing a first connection between an analyte sensor system and a display device. During the first connection, the method includes exchanging information related to authentication between the analyte sensor system and the display device. The method includes making a determination regarding whether authentication was performed during the first interval. During a second interval, the method may include establishing a second connection between the analyte sensor system and the display device for transmission of an encrypted analyte value, and bypassing the exchanging of information related to authentication performed during the first connection.
    Type: Application
    Filed: January 15, 2021
    Publication date: May 13, 2021
    Inventors: Aditya Mandapaka, Jorge Valdes, Jeffrey R. Wedekind, Eric Cohen, Douglas William Burnette, Francis William Pascual, Hari Hampapuram, Mark Dervaes, Michael Robert Mensinger
  • Patent number: 10945600
    Abstract: The present disclosure relates to systems, devices and methods for receiving biosensor data acquired by a medical device, e.g., relating to glucose concentration values, and controlling the access and distribution of that data. In some embodiments, systems and methods are disclosed for monitoring glucose levels, displaying data relating to glucose values and metabolic health information, and controlling distribution of glucose data between applications executing on a computer, such as a smart phone. In some embodiments, systems and methods are disclosed for controlling access to medical data such as continuously monitored glucose levels, synchronizing health data relating to glucose levels between multiple applications executing on a computer, and/or encrypting data.
    Type: Grant
    Filed: February 9, 2016
    Date of Patent: March 16, 2021
    Assignee: DexCom, Inc.
    Inventors: Michael Robert Mensinger, Esteban Cabrera, Jr., Eric Cohen, Nathaniel David Heintzman, Apurv Ullas Kamath, Gary A. Morris, Andrew Attila Pal, Eli Reihman, Jorge Valdes
  • Publication number: 20210007640
    Abstract: Systems and methods for a continuous monitoring of analyte values received from an analyte sensor system are provided. One method for a wireless data communication between an analyte sensor system and a mobile device involves storing identification information associated with a transceiver of the analyte sensor system, the identification information entered by a user of the mobile device via a custom application running on the mobile device; causing the custom application to enter a background mode; searching for advertisement signals; receiving an advertisement signal from the transceiver; authenticating the transceiver based on the identification information; prompting the user to bring the custom application to a foreground mode; causing the custom application to request a confirmation from the user that a data connection with the transceiver is desired; receiving the confirmation from the user; and completing the data connection with the transceiver.
    Type: Application
    Filed: September 28, 2020
    Publication date: January 14, 2021
    Inventors: Jose Hector Hernandez-Rosas, Shawn Larvenz, Mark Dervaes, Indrawati Gauba, Michael Robert Mensinger, Eric Cohen, Brian Christopher Smith, Jorge Valdes, Jacob S. Leach
  • Patent number: 10863931
    Abstract: Systems and methods for a continuous monitoring of analyte values received from an analyte sensor system are provided. One method for a wireless data communication between an analyte sensor system and a mobile device involves storing identification information associated with a transceiver of the analyte sensor system, the identification information entered by a user of the mobile device via a custom application running on the mobile device; causing the custom application to enter a background mode; searching for advertisement signals; receiving an advertisement signal from the transceiver; authenticating the transceiver based on the identification information; prompting the user to bring the custom application to a foreground mode; causing the custom application to request a confirmation from the user that a data connection with the transceiver is desired; receiving the confirmation from the user; and completing the data connection with the transceiver.
    Type: Grant
    Filed: November 25, 2019
    Date of Patent: December 15, 2020
    Assignee: DexCom, Inc.
    Inventors: Jose Hector Hernandez-Rosas, Shawn Larvenz, Mark Dervaes, Indrawati Gauba, Michael Robert Mensinger, Eric Cohen, Brian Christopher Smith, Jorge Valdes, Jacob S. Leach
  • Publication number: 20200345232
    Abstract: Systems, devices, and methods are disclosed for wireless communication of analyte data. One such method includes, during a first interval, establishing a first connection between an analyte sensor system and a display device. During the first connection, the method includes exchanging information related to authentication between the analyte sensor system and the display device. The method includes making a determination regarding whether authentication was performed during the first interval. During a second interval, the method may include establishing a second connection between the analyte sensor system and the display device for transmission of an encrypted analyte value, and bypassing the exchanging of information related to authentication performed during the first connection.
    Type: Application
    Filed: July 22, 2020
    Publication date: November 5, 2020
    Inventors: Aditya Mandapaka, Jorge Valdes, Jeffrey R. Wedekind, Eric Cohen, Douglas William Burnette, Francis William Pascual, Hari Hampapuram, Mark Dervaes, Michael Robert Mensinger
  • Publication number: 20200329966
    Abstract: A system is provided for monitoring analyte in a host, including a continuous analyte sensor that produces a data stream indicative of a host's analyte concentration and a device that receives and records data from the data stream from the continuous analyte sensor. In one embodiment, the device includes a single point analyte monitor, from which it obtains an analyte value, and is configured to display only single point analyte measurement values, and not any analyte measurement values associated with data received from the continuous analyte sensor. Instead, data received from the continuous analyte sensor is used to provide alarms to the user when the analyte concentration and/or the rate of change of analyte concentration, as measured by the continuous analyte sensor, is above or below a predetermined range. Data received from the continuous analyte sensor may also be used to prompt the diabetic or caregiver to take certain actions, such as to perform another single point blood glucose measurement.
    Type: Application
    Filed: July 7, 2020
    Publication date: October 22, 2020
    Inventors: Jorge Valdes, David Price, Leif N. Bowman, Kristin Koenekamp Cote
  • Publication number: 20200297840
    Abstract: This invention reveals the pharmaceutical composition that includes the surface antigen (HBsAg) of the hepatitis B virus (HBV) and the antigen of the nucleocapsid (or core, HBcAg) of the same virus. The HBcAg of this composition contains messenger ribonucleic acid (mRNA) at a proportion of over 45% of the total amount of ribonucleic acid (RNA) in this antigen. Because of the changes in the constitution of the antigens forming it, the composition of the invention is useful for the prevention or treatment of chronic hepatitis B. It also covers the use of this pharmaceutical composition in the production of a drug for immuno-prophylaxis or immunotherapy against HBV infection, and its use to increase the immune response against an additional antigen that is co-administered with the mixture of these antigens.
    Type: Application
    Filed: March 14, 2017
    Publication date: September 24, 2020
    Inventors: Julio César AGUILAR RUBIDO, Yadira LOBAINA MATO, Enrique IGLESIAS PEREZ, Eduardo PENTÓN ARIAS, Gerardo Enrique GUILLÉN NIETO, Jorge Agustín AGUIAR SANTIAGO, Sonia GONZALEZ BLANCO, Jorge VALDES HERNANDEZ, Mariela VAZQUEZ CASTILLO
  • Patent number: 10771607
    Abstract: Systems, devices, and methods are disclosed for wireless communication of analyte data. One such method includes, during a first interval, establishing a first connection between an analyte sensor system and a display device. During the first connection, the method includes exchanging information related to authentication between the analyte sensor system and the display device. The method includes making a determination regarding whether authentication was performed during the first interval. During a second interval, the method may include establishing a second connection between the analyte sensor system and the display device for transmission of an encrypted analyte value, and bypassing the exchanging of information related to authentication performed during the first connection.
    Type: Grant
    Filed: July 17, 2017
    Date of Patent: September 8, 2020
    Assignee: DexCom, Inc.
    Inventors: Aditya Mandapaka, Jorge Valdes, Jeffrey R. Wedekind, Eric Cohen, Douglas William Burnette, Francis William Pascual, Hari Hampapuram, Mark Dervaes, Michael Robert Mensinger